Seven Eight Capital’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-7,404
| Closed | -$925K | – | 556 |
|
2024
Q3 | $925K | Sell |
7,404
-17,280
| -70% | -$2.16M | 0.08% | 425 |
|
2024
Q2 | $3.9M | Buy |
24,684
+16,405
| +198% | +$2.59M | 0.41% | 42 |
|
2024
Q1 | $1.07M | Buy |
8,279
+2,330
| +39% | +$302K | 0.11% | 284 |
|
2023
Q4 | $574K | Buy |
+5,949
| New | +$574K | 0.07% | 393 |
|
2023
Q1 | – | Sell |
-2,280
| Closed | -$295K | – | 600 |
|
2022
Q4 | $295K | Buy |
+2,280
| New | +$295K | 0.08% | 313 |
|
2020
Q4 | – | Sell |
-1,700
| Closed | -$239K | – | 614 |
|
2020
Q3 | $239K | Buy |
+1,700
| New | +$239K | 0.05% | 490 |
|
2020
Q1 | – | Sell |
-51,574
| Closed | -$6.66M | – | 688 |
|
2019
Q4 | $6.66M | Sell |
51,574
-1,100
| -2% | -$142K | 0.35% | 77 |
|
2019
Q3 | $3.97M | Buy |
+52,674
| New | +$3.97M | 0.21% | 136 |
|
2018
Q3 | – | Sell |
-50,854
| Closed | -$6.72M | – | 697 |
|
2018
Q2 | $6.72M | Buy |
+50,854
| New | +$6.72M | 0.47% | 69 |
|
2017
Q3 | – | Sell |
-18,614
| Closed | -$627K | – | 604 |
|
2017
Q2 | $627K | Buy |
+18,614
| New | +$627K | 0.09% | 282 |
|
2016
Q3 | – | Sell |
-25,302
| Closed | -$483K | – | 529 |
|
2016
Q2 | $483K | Buy |
+25,302
| New | +$483K | 0.17% | 195 |
|
2016
Q1 | – | Sell |
-3,700
| Closed | -$143K | – | 675 |
|
2015
Q4 | $143K | Buy |
3,700
+3,300
| +825% | +$128K | 0.1% | 295 |
|
2015
Q3 | $13K | Buy |
+400
| New | +$13K | 0.01% | 435 |
|